Abstract
Purpose
Our objective was to compare the radial forces of several stents ex vivo to identify stents suitable for rescue of the unexpected coverage of aortic arch branches in thoracic endovascular aortic repair.
Methods
We measured the radial forces of two types of self-expanding bare nitinol stents (E-luminexx and Epic) used singly or as double-walled pairs, and of three endoprostheses used in thoracic endovascular aortic repair (TEVAR, Gore c-TAG, Relay, and Valiant) by compressing the stent using an MTS Instron universal testing machine (model #5582). We also examined the compressive effects of the TEVAR endoprostheses and the bare nitinol stents on each other.
Results
The radial force was greater in the center than at the edge of each stent. In all stents tested, the radial force decreased incrementally with increasing stent diameter. The radial force at the center was two times greater when using two stents than with a single stent. In the compression test, only E-luminexx used as a pair was not compressed after compressing a Relay endoprosthesis by 12 mm.
Conclusion
Two E-luminexx stents are appropriate to restore the blood flow if a TEVAR endoprosthesis covers the innominate artery following innominate–carotid–left subclavian arterial bypass.
Thoracic endovascular aortic repair (TEVAR) is a less invasive and potentially safer technique than open surgery, and is associated with lower morbidity and mortality rates compared with conventional treatment.1,2 It is increasingly performed and new devices are approved every year in the United States, Europe, Japan, and other countries.2,3 However, strict anatomical criteria limit the use of endoprostheses in many patients.4,5 One of the most common problems is a short proximal landing zone of < 2 cm. 6 To extend the indications for TEVAR, various methods like the chimney method and arterial debranching have been proposed, but the branches from the aortic arch must be preserved.5,7–9 To create a longer proximal landing zone, we perform innominate–carotid–left subclavian arterial bypass prior to TEVAR. In these short landing cases, we partially cover the innominate artery on purpose; however, sometimes we unexpectedly cover the innominate artery completely. When this happens, we avoid cerebral ischemia by placing bare stents at the occluded innominate artery. Because the innominate artery supplies blood to the brain following bypass, covering it could be fatal. This makes it essential to use a bare stent to maintain its patency. Few studies have assessed the optimal type of bare stent, relative position, or number of stents for use in this emergency situation. In this study, we compared the radial force of several stent types ex vivo, and examined the effects of stent position and number of stents, to determine which stent might be most suitable in this time-limited situation.
Methods
Stents
The ex vivo tests were done using two types of self-expanding bare nitinol stents and three types of TEVAR endoprostheses. The stents were E-luminexx (Bard Peripheral Vascular, Tempe, AZ, USA) and Epic (Boston Scientific Corporation, Cambridge, MA, USA). The TEVAR endoprostheses were GORE c-TAG Thoracic Endoprosthesis (W.L. Gore & Associates, Flagstaff, AZ, USA), Relay (Bolton Medical, Barcelona, Spain), and Valiant (Medtronic Vascular, Santa Rosa, CA, USA). The self-expanding bare nitinol stents had diameters of 8, 10, and 12 mm, and a length of 60 mm. The GORE c-TAG endoprosthesis had a diameter of 37 mm and a length of 100 mm. The Relay and Valiant endoprostheses had a diameter of 36 mm and a length of 150 mm.
Measurement of radial force and compression test
Radial forces were measured using an Instron universal testing instrument (model #5582, serial # C2531; Instron Worldwide Headquarters, Norwood, MA, USA) with Bluehill 2 testing software (version 2.5.391, serial:610763c; Instron Worldwide Headquarters). The load cell used in this study had a 100-N capacity. Tests were performed in a temperature-controlled chamber at 37℃, as previously described. 10 Radial force was measured three times at the end and three times at the center of each self-expanding bare nitinol stent after compressing the diameter from 8, 10, or 12 mm to 2 mm. The radial force of both ends of the TEVAR endoprosthesis was measured after compressing the diameter by 12 mm.
In the compression test, the Relay endoprosthesis and self-expanding bare nitinol stents were placed longitudinally at the edge on the Relay endoprosthesis, and were compressed with parallel plates to decrease the diameter by 12 mm to visualize the compressive effects of each stent.
All experiments were performed at the Osaka Municipal Technical Research Institute (Osaka, Japan). The testing machine was maintained and calibrated before testing.
Case report
The patient was 71years old and had the aortic arch aneurysm (60-mm diameter) located just below the left carotid artery. Informed consent from the patient was obtained by using a TEVAR endoprosthesis to treat a thoracic aortic arch aneurysm.
Statistical analysis
The effects of stent position, number, and type of stent on radial force were assessed using three-way analysis of variance. All analyses were performed using JMP® software version 9.0 (SAS Institute, Inc., Cary, NC, USA). Values of p < 0.05 were considered statistically significant.
Results
Self-expanding bare nitinol stents
Stent position
Radial forces of self-expanding bare nitinol stents according to the position, diameter, and type of stent graft used.
Values presented as means ± SE. p-Values were determined by three-way analysis of variance.
E-luminexx® (Bard Peripheral Vascular, Tempe, AZ, USA).
Epic® (Boston Scientific Corporation, Cambridge, MA, USA).
Effect of stent diameter and stent type
The radial force decreased incrementally with increasing stent diameter in all stent types (Table 1, F = 101.3; p < 0.0001). We also compared the radial force between individual E-luminexx and Epic bare nitinol stents and found that the radial force was 1.6 times greater for the E-luminexx stent than the Epic stent. (Table 1, F = 222.4; p < 0.0001).
Effects of stent number
Radial forces of self-expanding bare nitinol stents according to the number, diameter, and type of stent graft used.
Values presented as means of p-values were determined using three-way analysis of variance.
aE-luminexx® (Bard Peripheral Vascular, Tempe, AZ, USA).
bEpic® (Boston Scientific Corporation, Cambridge, MA, USA).
TEVAR endoprostheses
Comparison of the radial force of three types of endoprosthesis used in thoracic endovascular aortic repair.
Values presented as means ± SE. p-Values were determined using three-way analysis of variance.
GORE c-TAG® (W.L. Gore & Associates, Flagstaff, AZ, USA).
Relay® (Bolton Medical, Barcelona, Spain).
Valiant® (Medtronic Vascular, Santa Rosa, CA, USA).
Compression test of TEVAR endoprostheses and bare nitinol stents
In the compression test in which two types of stents were pressed into each other, compression of the Relay endoprosthesis by 12 mm resulted in the compression of the E-luminexx stent. In contrast, a pair of Epic stents was only slightly compressed and a pair of E-luminexx stents could not be compressed when compressing a Relay endoprosthesis by 12 mm (Figure 1).
Images of the compression tests with a Relay endoprosthesis (36 mm) and 12-mm diameter nitinol bare stents. (a) Compression of the Relay endoprosthesis and one E-luminexx without applying mechanical compression. (b) Compression of the Relay endoprosthesis by 12 mm with one E-luminexx. (c) Compression of the Relay endoprosthesis by 12 mm with two E-luminexx stent grafts. (d) Compression of the Relay endoprosthesis by 12 mm with two Epic stent grafts. The white arrow indicates the native diameter of the Relay endoprosthesis (36 mm). The yellow arrow indicates the diameter of the Relay endoprosthesis (24 mm) after being compressed by 12 mm. −, no compression; + , with compression of the Relay endoprosthesis by 12 mm.
Case report
We experienced a case in which a TEVAR endoprosthesis was used to treat a thoracic aortic arch aneurysm (Figure 2(a)). The endoprosthesis required an extended landing zone because a short proximal neck covered the innominate artery following unexpected innominate–carotid–left subclavian arterial bypass and limited blood supply to the brain. Blood flow was restored to the innominate artery by placing the middle portion of overlapped luminexx stents to the proximal edge of the aortic stent. Those luminexx stents were implanted from right brachial artery. (Figure 2(b)). At 1 year after the procedure, the patient's blood flow was intact and he had no comorbidities. Postoperative computed tomography showed that the entire circumference of the TEVAR endoprothesis was compressed by the thoracic aorta. In addition, the double-wall E-luminexx stents were compressed between the thoracic aorta and the Relay TEVAR endoprothesis in parallel (Figure 2(c) and (d)).
Images of a representative case in which the innominate artery, which supplies all of the blood to the brain, was covered by a TEVAR endoprosthesis during innominate–carotid–left subclavian arterial bypass. (a) Preoperative three-dimensional computed tomographic (3DCT) image of the aortic arch aneurysm (60-mm diameter) located just below the left carotid artery. The length of the proximal landing zone on the lesser curve of the aortic arch was 11 mm from the innominate artery. (b) Postoperative 3DCT image obtained after inserting two Relay endoprostheses (diameter × length; 42/38 × 200 mm2 and 42 × 100 mm2) and two E-luminexx stents (14 × 60 mm2 and 14 × 40 mm2) following innominate–left carotid–left subclavian arterial bypass. Axial (c) and cross-sectional (d) postoperative CT images show that the TEVAR endoprosthesis compressed both E-luminexx stents.
Discussion
In this study, we determined the radial forces of two types of self-expanding bare nitinol stents and three types of TEVAR endoprostheses ex vivo. Notably, we found that using two E-luminexx bare stents was appropriate for rapid rescue to restore blood flow compressed by the TEVAR endoprosthesis.
There are two methods to measure the radial force of stents. 10 The first method involves compressing the whole circumference of the stent equally. This approach provides an indication of recoil and concentric stenosis. The other method involves compressing the stent between two parallel plates and provides an indication of eccentric stenosis caused by localized smooth muscle cell proliferation. In this study, we used the second method to simultaneously compress the bare stents and TEVAR endoprostheses to mimic the clinical condition in which it is difficult to compress the entire circumferences of both stents at the same time.
The balloon-inflated stents commonly used by many centers have a greater radial force than self-expanding nitinol stents. However, balloon-inflated stents are completely inelastic, are at risk of permanent compression, and may migrate after insertion. Additionally, it takes some time to restore blood flow after inserting a balloon-inflated stent.11–15 Considering these features, self-expanding bare nitinol stents may be more suitable to cover the innominate artery when unexpected vascular reconstruction is urgently needed.
The present study also showed that the radial force of self-expanding nitinol stents was greater at their centers than at their edges. This suggests that self-expanding stents should be placed to ensure the center of the stent is adjacent to the stenosis lesion.
We also found that the radial force decreased with increasing stent diameter, consistent with prior research. 16 Of note, the radial force of two 12-mm stents was approximately 3 N, and was three times greater than the radial force associated with compressing the circumference of the TEVAR endoprostheses to 12 mm.
The results of the compression test suggest that a pair of E-luminexx stents is resistant to compression by a TEVAR endoprosthesis. However, in the clinical case described, computed tomography demonstrated that a double E-luminexx stent was compressed by the TEVAR prosthesis. In this patient, the entire circumference of the TEVAR endoprosthesis was compressed by the thoracic aorta. This radial force was more than four times greater than the radial force measured when compressing two stents in parallel, based on a comparison between our present results and our previously reported results. 17 For this reason, the radial force placed on the TEVAR endoprosthesis increases the compression of the bare stent. Therefore, it is essential that the surgeon evaluates the possibility of stent deformities during and after surgery.
Regarding the additional stent, we hypothesized that it would be better to insert a larger diameter bare stent than multiple smaller stents because the radial force could increase with increased number of stents. In fact, the stent lumen was intact, but the stent was clearly deformed. In our previous study, the radial force associated with compressing the diameter of the stent by 12 mm was six times greater than the radial force when two stents were compressed in parallel by 12 mm. This may explain why the stent was deformed in our case. The compression ratio might be determined by the size of the TEVAR endoprosthesis relative to the aorta, the size of the stenotic lesion, and the balance between the radial force associated with compressing the TEVAR endoprosthesis and the radial force associated with compressing the bare stent in parallel.
The radial force of compressing pairs of GORE C-TAG stents was not significantly different from that of compressing the Relay and Valiant stents. However, the radial force across the entire circumference of the GORE c-TAG stent when oversizing was significantly greater than that of other two TEVAR stents. 17 Further studies are needed to clarify the radial force between the bare stent and a GORE c-TAG stent when oversizing.
Conclusion
In case a TEVAR endoprosthesis unexpectedly covered the innominate artery by implanting the proximal edge of prosthesis just below the innominate artery, which has innominate–carotid–left subclavian arterial bypass prior to placing prosthesis, placing two E-luminexx stents are effective to restore the blood flow from this coverage.
Footnotes
Acknowledgments
We wish to thank Rie Nishikuma for editorial assistance, Junji Kishimoto for statistical advice, and Nicholas Smith for language editing. We also thank Bard Peripheral Vascular, Boston Scientific Corporation, W.L. Gore & Associates, Bolton Medical, and Medtronic Vascular, Inc. for donating the stents used in this study.
Declaration of conflicting interests
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Funding
The author(s) received no financial support for the research, authorship, and/or publication of this article.
